Compare RDY & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | IT |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | India | United States |
| Employees | N/A | 40 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.8B |
| IPO Year | 2001 | 2010 |
| Metric | RDY | IT |
|---|---|---|
| Price | $15.32 | $134.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | $16.90 | ★ $189.25 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $2,021,441,000.00 |
| Revenue This Year | $7.72 | $3.52 |
| Revenue Next Year | $3.50 | $5.08 |
| P/E Ratio | ★ $18.67 | $39.86 |
| Revenue Growth | N/A | ★ 13.30 |
| 52 Week Low | $12.19 | $124.25 |
| 52 Week High | $15.27 | $409.76 |
| Indicator | RDY | IT |
|---|---|---|
| Relative Strength Index (RSI) | 78.69 | 40.45 |
| Support Level | $13.80 | N/A |
| Resistance Level | N/A | $162.80 |
| Average True Range (ATR) | 0.29 | 6.41 |
| MACD | 0.23 | -2.13 |
| Stochastic Oscillator | 85.91 | 26.82 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.